Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
910,188
-
Share change
-
-134,941
-
Total reported value
-
$56,421,786
-
Price per share
-
$62.01
-
Number of holders
-
86
-
Value change
-
-$8,928,314
-
Number of buys
-
20
-
Number of sells
-
44
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q1 2022
As of 31 Mar 2022,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
910,188 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, Artemis Wealth Advisors, LLC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, UBS Group AG, Cetera Advisor Networks LLC, YHB Investment Advisors, Inc., and Institute for Wealth Management, LLC..
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.